S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
NASDAQ:KERN

Akerna (KERN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.31
$9.80
52-Week Range
N/A
Volume
70,795 shs
Average Volume
339,022 shs
Market Capitalization
$64.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
KERN stock logo

About Akerna Stock (NASDAQ:KERN)

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

KERN Stock News Headlines

Akerna Corp. Simplifies Stock Structure, Alters Fiscal Year
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
Gryphon Digital Mining, Inc. Debuts on Nasdaq
Gryphon Digital Mining Debuts on Nasdaq
Akerna Corp Ordinary Shares
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
Akerna Corp. Wt
Why Akerna Stock Is Exploding Higher Today
Akerna (NASDAQ: KERN)
Akerna to Sell its Cannabis Software Business
See More Headlines
Receive KERN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akerna and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2021
Today
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Nondepository credit institutions
Sub-Industry
N/A
Current Symbol
NASDAQ:KERN
Fax
N/A
Employees
112
Year Founded
N/A

Profitability

Net Income
$-79,060,000.00
Net Margins
-339.99%
Pretax Margin
-208.10%

Debt

Sales & Book Value

Annual Sales
$13.65 million
Book Value
($1.52) per share

Miscellaneous

Free Float
10,228,000
Market Cap
$64.92 million
Optionable
No Data
Beta
3.02
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Jessica Billingsley (Age 47)
    Founder, CEO & Chairman of the Board
    Comp: $462.3k
  • Mr. Larry Dean Ditto Jr. (Age 57)
    Chief Financial Officer
    Comp: $177.71k
  • Mr. David R. McCullough (Age 47)
    Chief Technology Officer
    Comp: $240.43k
  • Georgia Jablon
    Communications Manager

KERN Stock Analysis - Frequently Asked Questions

How were Akerna's earnings last quarter?

Akerna Corp. (NASDAQ:KERN) announced its quarterly earnings results on Sunday, November, 7th. The company reported ($2.80) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($3.00) by $0.20. The firm earned $5.14 million during the quarter, compared to the consensus estimate of $5.11 million. During the same quarter in the previous year, the firm earned ($6.80) EPS.

When did Akerna's stock split?

Shares of Akerna reverse split on the morning of Friday, February 9th 2024. The 1-20 reverse split was announced on Friday, February 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 9th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Akerna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akerna investors own include KushCo (KSHB), Organigram (OGI), Supreme Cannabis (SPRWF), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Medical Marijuana (MJNA), MariMed (MRMD), Matinas BioPharma (MTNB), CNBX Pharmaceuticals (CNBX) and DHT (DHT).

This page (NASDAQ:KERN) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners